Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


NBTY Online Focus, Retail Expansion Leads To Late 1999 Stock Climb

This article was originally published in The Tan Sheet

Executive Summary

NBTY's continued commitment to expanding its retail business, as well as its heightened emphasis on Internet operations, appear to have been favorably received by Wall Street onlookers toward the end of 1999.

You may also be interested in...

CFSAN 10-Year Dietary Supplement Strategy Comprises Six Core Areas

The creation of an advisory committee or "standing group" on dietary supplements is one of the priorities under the FDA Center for Food Safety & Applied Nutrition's 10-year plan for supplement regulation.

Hot Flashes, PMS Structure/Function Claims Allowed Under Final Rule

FDA will permit dietary supplement makers to make structure/function claims for "common, mild symptoms associated with normal life stages or processes." Examples of allowable claims include hot flashes associated with menopause and mild mood changes, cramps and edema related to the menstrual cycle.

Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts